Your browser doesn't support javascript.
loading
IgG4-related disease in the Japanese population: a genome-wide association study.
Terao, Chikashi; Ota, Masao; Iwasaki, Takeshi; Shiokawa, Masahiro; Kawaguchi, Shuji; Kuriyama, Katsutoshi; Kawaguchi, Takahisa; Kodama, Yuzo; Yamaguchi, Izumi; Uchida, Kazushige; Higasa, Koichiro; Yamamoto, Motohisa; Kubota, Kensuke; Yazumi, Shujiro; Hirano, Kenji; Masaki, Yasufumi; Maguchi, Hiroyuki; Origuchi, Tomoki; Matsui, Shoko; Nakazawa, Takahiro; Shiomi, Hideyuki; Kamisawa, Terumi; Hasebe, Osamu; Iwasaki, Eisuke; Inui, Kazuo; Tanaka, Yoshiya; Ohshima, Koh-Ichi; Akamizu, Takashi; Nakamura, Shigeo; Nakamura, Seiji; Saeki, Takako; Umehara, Hisanori; Shimosegawa, Tooru; Mizuno, Nobumasa; Kawano, Mitsuhiro; Azumi, Atsushi; Takahashi, Hiroki; Mimori, Tsuneyo; Kamatani, Yoichiro; Okazaki, Kazuichi; Chiba, Tsutomu; Kawa, Shigeyuki; Matsuda, Fumihiko.
Afiliação
  • Terao C; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ota M; Department of Internal Medicine 2, School of Medicine, Shinshu University, Matsumoto, Japan.
  • Iwasaki T; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan.
  • Shiokawa M; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Kawaguchi S; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kuriyama K; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Kawaguchi T; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kodama Y; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Yamaguchi I; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Uchida K; Department of Gastroenterology and Hepatology Kansai Medical University, Hirakata, Japan.
  • Higasa K; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yamamoto M; Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kubota K; Department of Endoscopy, Yokohama City University Hospital, Yokohama, Japan.
  • Yazumi S; Department of Gastroenterology and Hepatology, Kitano Hospital, Osaka, Japan.
  • Hirano K; Department of Gastroenterology, Tokyo Takanawa Hospital, Tokyo, Japan.
  • Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan.
  • Maguchi H; Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.
  • Origuchi T; Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Matsui S; Center for Health Care and Human Sciences, University of Toyama, Toyama, Japan.
  • Nakazawa T; Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Shiomi H; Department of Gastroenterology, Kobe University Hospital, Kobe, Japan.
  • Kamisawa T; Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
  • Hasebe O; Department of Gastroenterology, Nagano Municipal Hospital, Tomitake, Japan.
  • Iwasaki E; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Inui K; Department of Gastroenterology, Second Teaching Hospital, Fujita Health University, Toyoake, Japan.
  • Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Ohshima KI; Department of Ophthalmology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Akamizu T; First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
  • Nakamura S; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Nakamura S; Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
  • Saeki T; Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan.
  • Umehara H; Division of Rheumatology and Immunology, Nagahama City Hospital, Nagahama, Japan.
  • Shimosegawa T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kawano M; Department of Rheumatology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Azumi A; Department of Ophthalmology, Kobe Kaisei Hospital, Kobe, Japan.
  • Takahashi H; Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Mimori T; Department of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan.
  • Kamatani Y; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Okazaki K; Department of Gastroenterology and Hepatology Kansai Medical University, Hirakata, Japan.
  • Chiba T; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Kawa S; Center for Health Safety and Environmental Management, Shinshu University, Matsumoto, Japan.
  • Matsuda F; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: fumi@genome.med.kyoto-u.ac.jp.
Lancet Rheumatol ; 1(1): e14-e22, 2019 Sep.
Article em En | MEDLINE | ID: mdl-38229354
ABSTRACT

BACKGROUND:

IgG4-related disease is a newly recognised immunopathological entity that includes autoimmune pancreatitis, IgG4-related sialadenitis, and IgG4-related kidney disease. To understand the genetic landscape of IgG4-related disease, we did a genome-wide association study.

METHODS:

We did a genome-wide association study of Japanese individuals, initially screening 857 patients with IgG4-related disease at 50 Japanese research institutions and DNA samples from 2082 healthy control participants from the Nagahama Prospective Genome Cohort for the Comprehensive Human Bioscience. From Oct 27, 2008, to July 22, 2014, we enrolled 835 patients and used data from 1789 healthy participants. Only patients with confirmed diagnosis of IgG4-related disease according to the international diagnostic criteria were included. Genotyping was done with the Infinium HumanOmni5Exome, HumanOmni2.5Exome, or HumanOmni2.5 Illumina arrays, and genomic distributions were compared between case and control samples for 958 440 single nucleotide polymorphisms. The HLA region was extensively analysed using imputation of HLA alleles and aminoacid residues. Fine mapping of the FCGR2B region was also done. Associations between clinical manifestations of disease and the genetic variations identified in these two genes were examined.

FINDINGS:

We identified the HLA-DRB1 (p=1·1×10-11) and FCGR2B (p=2·0×10-8) regions as susceptibility loci for IgG4-related disease. We also identified crucial aminoacid residues in the ß domain of the peptide-binding groove of HLA-DRB1, in which the seventh aminoacid residue showed the strongest association signal with IgG4-related disease (p=1·7×10-14), as has been reported with other autoimmune diseases. rs1340976 in FCGR2B showed an association with increased FCGR2B expression (p=2·7×10-10) and was in weak linkage disequilibrium with rs1050501, a missense variant of FCGR2B previously associated with systemic lupus erythematosus. Furthermore, rs1340976 was associated with the number of swollen organs at diagnosis (p=0·011) and IgG4 concentration at diagnosis (p=0·035).

INTERPRETATION:

Two susceptibility loci for IgG4-related disease were identified. Both FCGR2B and HLA loci might have important roles in IgG4-related disease development. Common molecular mechanisms might underlie IgG4-related disease and other immune-related disorders

FUNDING:

The Japanese Ministry of Health, Labour, and Welfare, the Japanese Agency of Medical Research and Development, and Kyoto University Grant for Top Global University Japan Project.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article